Submissions from 2019
Method of Predicting Obesity Comprising Measuring Neurotensin, B. Mark Evers, Jing Li, Paul Dobner, and Olle Melander
RNA-Based Compositions and Adjuvants for Prophylactic and Therapeutic Treatment, Peixuan Guo, Hui Li, Emil F. Khisamutdinov, and Daniel L. Jasinski
Cytisine-Linked Isoflavonoid Antineoplastic Agents for the Treatment of Cancer, Chunming Liu, David S. Watt, Mykhaylo S. Frasinyuk, Vitaliy M. Sviripa, Wen Zhang, and Svitlana P. Bondarenko
Phenylethynyl-Substituted Benzenes and Heterocycles for the Treatment of Cancer, David S. Watt, Chunming Liu, Vitaliy M. Sviripa, Wen Zhang, and Markos Leggas
Submissions from 2018
Halogenated Diarylacetylenes and Methods of Treating Cancer, Vitaliy M. Sviripa, Wen Zhang, Chunming Liu, and David S. Watt
Arylquinoline and Analog Compounds and Use Thereof to Treat Cancer, David S. Watt, Chunming Liu, Vivek M. Rangnekar, Vitaliy M. Sviripa, Ravshan Burikhanov, and Wen Zhang
Submissions from 2017
3-aryl-4H-chromene-4-ones as Antineoplastic Agents for the Treatment of Cancer, Svitlana P. Bondarenko, Mykhaylo S. Frasinyuk, Chunming Liu, and David S. Watt
Submissions from 2016
Use of Parthenolide Derivatives as Antileukemic and Cytotoxic Agents, Peter A. Crooks, Craig T. Jordan, and Xiaochen Wei
Ex Vivo and In Vivo Methods and Related Compositions for Regenerating Hematopoietic Stem Cell Populations, Gary Van Zant and Ying Liang
Submissions from 2015
Stilbene Analogs and Methods of Treating Cancer, David Watt, Chunming Liu, Vitaliy M. Sviripa, and Wen Zhang
Submissions from 2014
Stilbene Analogs and Methods of Treating Cancer, David Watt, Chunming Liu, Vitaliy M. Sviripa, and Wen Zhang
Submissions from 2010
Organic Cation Transporter Preferentially Expressed in Hematopoietic Cells and Leukemias and Uses Thereof, Jeffrey A. Moscow, Xin Lu, and Craig Jordan
Submissions from 2009
Monoclonal Antibody 1A7 and Use for the Treatment of Melanoma and Small Cell Carcinoma, Malaya Chatterjee, Kenneth A. Foon, and Sunil K. Chatterjee
Methods and Devices for Cryopreservation of Biological Cells and Tissues, Dayong Gao, Gary Van Zant, and XiangDong Cui
Submissions from 2008
Murine Monoclonal Anti-Idiotype Antibody 11D10 and Methods of Use Thereof, Malaya Chatterjee, Kenneth A. Foon, and Sunil K. Chatterjee
Submissions from 2006
Highly Lipophilic Camptothecin Intermediates and Prodrugs and Methods of Preparation Thereof, Thomas G. Burke, Dennis P. Curran, and Wu Du
Submissions from 2005
Murine Monoclonal Anti-Idiotype Antibody 11D10 and Methods of Use Thereof, Malaya Chatterjee, Kenneth A. Foon, and Sunil K. Chatterjee
Submissions from 2004
Methods to Impair Hematologic Cancer Progenitor Cells and Compounds Related Thereto, Craig Jordan
Submissions from 2003
Monoclonal Antibody 1A7 and Use for the Treatment of Melanoma and Small Cell Carcinoma, Malaya Chatterjee, Kenneth A. Foon, and Sunil K. Chatterjee
Submissions from 2002
Methods and Compositions for the Treatment of Psoriasis, Kenneth A. Foon and Malaya Chatterjee
Submissions from 1999
Monoclonal Antibody 1A7 and Related Polypeptides, Malaya Chatterjee, Kenneth A. Foon, and Sunil K. Chatterjee
Polynucleotides Related to Monoclonal Antibody 1A7 and Use for the Treatment of Melanoma and Small Cell Carcinoma, Malaya Chatterjee, Kenneth A. Foon, and Sunil K. Chatterjee
Murine Anti-Idiotype Antibody 3H1, Malaya Chatterjee, Heinz Köhler, Sunil K. Chatterjee, and Kenneth A. Foon
Submissions from 1997
Anti-Idiotype Monoclonal Antibody 1A7 and Use for the Treatment of Melanoma and Small Cell Carcinoma, Malaya Chatterjee and Kenneth A. Foon
